John Manalo, MD
Orthopaedic Surgery · Fort Wayne, INNPI 1043506694
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Zimmer Biomet at 59.3% of the total. Reporting peaked in 2021 at $11,045 and has fallen 99.7% since, to $29 in 2025.
Across 89 payments — averaging $183.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$10K
- Johnson & Johnson$4K
- Stryker$2K
- Smith+Nephew$379
- Medical Device Business Services, Inc.$172
- Heron Therapeutics, Inc.$29
- plus $14 from 1 others
What the payments were for
- Consulting fees$9,00055%
- Travel & lodging$3,21320%
- Food & beverage$4,10025%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 19 | $9,682 |
| Johnson & Johnson | 17 | $3,737 |
| Stryker | 31 | $2,301 |
| Smith+Nephew | 17 | $379 |
| Medical Device Business Services, Inc. | 3 | $172 |
| Heron Therapeutics, Inc. | 1 | $29 |
| Pacira Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,313 in reported general payments places this provider in the 75th percentile of 400 orthopaedic surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 297 | $11,047 |
| Diclofenac Sodium | 96 | $1,608 |
| Methocarbamol | 68 | $818 |
| Prednisone | 209 | $496 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $405 |
| Meloxicam | 151 | $319 |
| Cyclobenzaprine Hcl | 23 | $318 |
| Oxycodone Hcl | 41 | $293 |
| Tramadol Hcl | 61 | $183 |
| Methylprednisolone | 23 | $152 |
| Cefadroxil | 11 | $134 |
| Hydromorphone Hcl | 18 | $132 |
| Amoxicillin | 108 | $96 |
| Tizanidine Hcl | 11 | $60 |
| Clindamycin Hcl | 24 | $46 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Fort Wayne
- John WilliamsFort Wayne$2.7M
- Alan McGeeFort Wayne$1.1M
- Micah SmithFort Wayne$674K
- Alan McGeeFort Wayne$135K
- Brandon HugginsFort Wayne$87K
- Christopher JohnsonFort Wayne$86K
- Michael LeeFort Wayne$42K
- Frank KolisekGreenwood$7.5M
- David FisherIndianapolis$5.9M
- Michael BerendIndianapolis$4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.